Skip to main content
. 2009 Jul 1;20(10):1915–1926. doi: 10.1007/s10552-009-9385-0

Fig. 3.

Fig. 3

Kaplan–Meier survival curves for biochemical recurrence of prostate cancer for GST polymorphisms in high versus low tumor stage: a GSTM1 null versus GSTM1 present (log rank p < 0.0001); b GSTT1 null versus GSTT1 present (log rank p < 0.0001); c GSTP1 codon 105 Ile/Ile and Ile/Val versus Val/Val (log rank p < 0.0001) and d total number of GST high risk (variant) genotypes (log rank p < 0.0001)